CASE REPORTS: Clitoral Atrophy: A Case Series
Version of Record online: 6 NOV 2008
© 2008 International Society for Sexual Medicine
The Journal of Sexual Medicine
Volume 6, Issue 2, pages 584–587, February 2009
How to Cite
Amsterdam, A. and Krychman, M. (2009), CASE REPORTS: Clitoral Atrophy: A Case Series. Journal of Sexual Medicine, 6: 584–587. doi: 10.1111/j.1743-6109.2008.01044.x
- Issue online: 27 JAN 2009
- Version of Record online: 6 NOV 2008
Vol. 6, Issue 5, 1493, Version of Record online: 27 APR 2009
- Clitoral Atrophy;
- Female Sexual Dysfunction
Introduction. Clitoral atrophy is often a neglected cause of female arousal complaints and warrants treatment with localized treatments.
Aim. This is a case series of patients with clitoral atrophy in which localized estrogens were used to treat separate, distinct sexual complaints.
Methods. We report on three patients who were treated with localized estrogen tablets and cream for symptomatic clitoral atrophy despite a lack of data for use of these agents for the treatment of this diagnosis. The patients described here expressed understanding of the risks of vaginal hormonal therapy prior to treatment and at follow-up visits while on therapy.
Main Outcome Measures. Patient reports, physical examination, and vaginal pH.
Results. All patients reported improvement or resolution of symptoms after the treatment with localized estrogen tablets and/or cream.
Conclusions. Low-dose minimally absorbed local estrogen products can be used in combination with excellent tolerance and low side-effect profile to treat female sexual complaints. Amsterdam A, and Krychman M. Clitoral atrophy: A case series. J Sex Med 2009;6:584–587.